Polymorphisms of DNA base-excision repair genes APE/Ref-1 and XRCC1 are not associated with the risk for Graves' disease

Cell Biochemistry and Function

Volumn 27, Issue 7, 2009, Pages 462-467

  Doǧru Abbasoǧlu, Semra ^a   Tanrikulu, Sevda ^a   Ademoǧlu, Evin ^a   Erbil, Yeşim ^a   Özderya, Ayşenur ^b   Karadaǧ, Berrin ^b   Uysal, Müjdat ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b SISLI ETFAL TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

APE Ref 1; DNA repair; Graves' disease; Polymorphism; XRCC1

Indexed keywords

REDOX EFFECTOR FACTOR 1; XRCC1 PROTEIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CODON; CONTROLLED STUDY; EXCISION REPAIR; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; GRAVES DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; CODON; DNA REPAIR; DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE; DNA-BINDING PROTEINS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GRAVES DISEASE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; NUCLEIC ACID DENATURATION; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 70350604382     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.1595     Document Type: Article

References (39)

1. Ban Y, Tomer Y. Susceptibility genes in thyroid autoimmunity. Clin Dev Immunol 2005; 12: 47-58.
2. Vaidya B, Kendall-Taylor P, Pearce SHS. Genetics of endocrine disease. The genetics of autoimmune thyroid disease. J Clin Endocrinol Metab 2002; 87: 5385-5397. (Pubitemid 36034331)
3. Dittmar M, Kahaly GJ. Immunoregulatory and susceptibility genes in thyroid and polyglandular autoimmunity. Thyroid 2005; 15: 239-250. (Pubitemid 40418691)
4. Guarnieri F, Benvenga S. Environmental factors and genetic background that interact to cause autoimmune thyroid disease. Curr Opin Endocrinol Diab Obes 2007; 14: 398-409.
5. 2a in females with Graves' hyperthyroidism. Prostaglandins Leukot Essent Fatty Acids 2004; 71: 143-147.
6. Ademoglu E, Ozbey N, Erbil Y, et al. Determination of oxidative stress in thyroid tissue and plasma of patients with Graves' disease. Eur J Intern Med 2006; 17: 545-550. (Pubitemid 44827700)
7. Lampka M, Junik R, Nowicka A, Kopcznska E, Tyrakowski T, Odrowaz- Sypniewska G. Oxidative stress markers during a course of hyperthyroidism. Endokrynol Pol 2006; 57: 218-222.
8. Rybus-Kalinowska B, Zwirska-Korczala K, Kalinowski M, Kukla M, Bikner E, Jochem J. Activity of antioxidative enzymes and concentration of malondialdehyde as oxidative status markers in women with newly diagnosed Graves-Basedow disease and after thiamazole therapy leading to euthyroidism. Pol Arch Med Wewn 2008; 118: 420-425.
9. Tang XL, Liu XJ, Sun WM, Zhao J, Zheng RL. Oxidative stress in Graves' disease patients and antioxidant protection against lymphocytes DNA damage in vitro. Pharmazie 2005; 60: 696-700. (Pubitemid 41345463)
10. Hara H, Sato R, Ban Y. Production of 8-OHdG and cytochrome c by cultured human mononuclear cells in patients with autoimmune thyroid disease. Endocr J 2001; 48: 671-675. (Pubitemid 34032337)
11. Tsai CC, Kao SC, Cheng CY, et al. Oxidative stress change by systemic corticosteroid treatment among patients having active Graves opthalmopathy. Arch Opthalmol 2007; 125: 1652-1656.
12. Seeberg E, Eide L, Bjoras M. The base excision repair pathway. Trends Biochem Sci 1995; 20: 391-397.
13. Hadi MZ, Coleman MA, Fidelis K, Mohrenweiser HW, Wilson DM. Functional characterization of Ape1 variants identified in the human population. Nucleic Acids Res 2000; 28: 3871-3879. (Pubitemid 30784436)
14. Izumi T, Hazra TK, Boldogh I, et al. Requirement for human AP endonuclease 1 for repair of 3′-blocking damage at DNA single strand breaks induced by reactive oxygen species. Carcinogenesis 2000; 21: 1329-1334. (Pubitemid 30455991)
15. Terry PD, Umbach DM, Taylor JA. APE1 genotype and risk of bladder cancer: Evidence for effect modification by smoking. Int J Cancer 2006; 118: 3170-3173.
16. Campalans A, Marsin S, Nakabeppu Y, O'Connor TR, Boiteux S, Radicella JP. XRCC1 interacts with multiple DNA glycosylases: A model for its recruitment to base excision repair. DNA Repair (Amst) 2005; 4: 826-835.
17. Tudek B. Base excision repair modulation as a risk factor for human cancers. Mol Aspects Med 2007; 28: 258-275. (Pubitemid 47331613)
18. Marsin S, Vidal AE, Sossou M, et al. Role of XRCC1 in the coordination and stimulation of oxidative DNA damage repair initiated by the DNA glycosylase hOGG1. J Biol Chem 2003; 278: 44068-44074. (Pubitemid 37377147)
19. Chang-Claude J, Popanda O, Tan X-L, et al. Associations between polymorphisms in the DNA repair genes, XRCC1, APE1, and XPD and acute side effects of radiotherapy in breast cancer patients. Clin Cancer Res 2005; 11: 4802-4809. (Pubitemid 41557201)
20. Dogru-Abbasoglu S, Aykac-Toker G, Hanagasi HA, Gurvit H, Emre M, Uysal M. The Arg194Trp polymorphism in DNA repair gene XRCC1 and the risk for sporadic late-onset Alzheimer's disease. Neurol Sci 2007; 28: 31-34. (Pubitemid 46502077)
21. Guven M, Guven GS, Oz E, et al. DNA repair gene XRCC1 and XPD polymorphisms and their association with coronary artery disease risks and micronucleus frequency. Heart Vessels 2007; 22: 355-360. (Pubitemid 350201430)
22. Unal M, Guven M, Batar B, Ozaydin A, Sarici A, Devranoglu K. Polymorphisms of DNA repair genes XPD and XRCC1 and risk of cataract development. Exp Eye Res 2007; 328-334. (Pubitemid 47259050)
23. Tekeli A, Isbir S, Ergen A, et al. APE1 and XRCC3 polymorphisms and myocardial infarction. In Vivo 2008; 22: 477-479.
24. Parildar-Karpuzoglu H, Dogru-Abbasoglu S, Hanagasi HA, et al. Single nucleotide polymorphisms in base-excision repair genes hOGG1, APE1 and XRCC1 do not alter risk of Alzheimer's disease. Neurosci Lett 2008; 442: 287-291.
25. Tell G, Damante G, Caldwell ID, Kelley MR. The intracellular localization of APE1/Ref-1: More than a passive phenomenon? Antiox Redox Signal 2005; 7: 367-384.
26. Tell G, Quadrifoglio F, Tiribelli C, Kelley MR. The many functions of APE1/Ref-1: Not only a DNA repair enzyme. Antiox Redox Signal 2009; 11: 601-620.
27. Tell G, Pellizzari L, Pucillo C, et al. TSH controls Ref-1 nuclear translocation in thyroid cells. J Mol Endocrinol 2000; 24: 383-390. (Pubitemid 30415012)
28. Tell G, Pellizzari L, Cimarosti D, Pucillo C, Damante G. Ref-1 controls Pax-8 DNA-binding activity. Biochem Biophys Res Commun 1998; 252: 178-183. (Pubitemid 28534647)
29. Russo D, Celano M, Bulotta S, et al. APE/Ref-1 is increased in nuclear fractions of human thyroid hyperfunctioning nodules. Mol Cell Endocrinol 2002; 194: 71-76.
30. Popanda O, Schattenberg T, Phong CT, et al. Specific combinations of DNA repair gene variants and increased risk for non-small cell lung cancer. Carcinogenesis 2004; 25: 2433-2441. (Pubitemid 39625184)
31. Li C, Liu Z, Wang LE, et al. Genetic variants of ADPRT, XRCC1 and APE1 genes and risk of cutaneous melanoma. Carcinogenesis 2006; 27: 1894-1901.
32. Li J, Bondy ML, Hassan MM, et al. Selected polymorphisms of DNA repair genes and risk of pancreatic cancer. Cancer Detect Prev 2006; 30: 284-291. (Pubitemid 44163055)
33. Caldecott KW. XRCC1 and DNA strand break repair. DNA Repair (Amst) 2007; 2: 955-969.
34. Hung RJ, Hall J, Brennan P, Boffetta P. Genetic polymorphisms in the base excision repair pathway and cancer risk: A HuGE review. Am J Epidemiol 2005; 162: 925-942. (Pubitemid 41619464)
35. Wang Y, Spitz MR, Zhu Y, Dong Q, Shete S, Wu X. From genotype to phenotype: Correlating XRCC1 polymorphisms with mutagen sensitivity. DNA Repair (Amst) 2003; 2: 901-908. (Pubitemid 37297454)
36. Lei YC, Hwang SJ, Chang CC, et al. Effects on sister chromatid exchange frequency of polymorphisms in DNA repair gene XRCC1 in smokers. Mutat Res 2002; 519: 93-101. (Pubitemid 34874990)
37. Duell EJ, Wiencke JK, Cheng TJ, et al. Polymorphisms in the DNA repair genes XRCC1 and ERCC2 and biomarkers of DNA damage in human blood mononuclear cells. Carcinogenesis 2000; 21: 965-971.
38. 32P-DNA adducts in a sample of healty subjects. Carcinogenesis 2001; 22: 1437-1445.
39. Hu Z, Ma H, Chen F, Wei Q, Shen H. XRCC1 polymorphisms and cancer risk: A meta-analysis of 38 case-control studies. Cancer Epidemiol Biomarkers Prev 2005; 14: 1810-1818. (Pubitemid 40995099)